Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 155

    1.

    Immunoglobulin G Fc Receptor Fc{gamma}RIIIa 158 V/F Polymorphism Correlates With Rituximab-Induced Neutropenia After Autologous Transplantation in Patients With Non-Hodgkin's Lymphoma.

    Weng WK, Negrin RS, Lavori P, Horning SJ.

    J Clin Oncol. 2009 Nov 23. [Epub ahead of print]PMID: 19933905 [PubMed - as supplied by publisher]Related articles

    2.

    Thomas' Hematopoietic Cell Transplantation.

    Appelbaum FR, Forman SJ, Negrin RS, Blume KG.

    Eur J Haematol. 2009 Oct 14. [Epub ahead of print] No abstract available. PMID: 19840108 [PubMed - as supplied by publisher]Related articles

    3.

    Salvage allogeneic hematopoietic cell transplantation with fludarabine and low-dose total body irradiation after rejection of first allografts.

    Gyurkocza B, Cao TM, Storb RF, Lange T, Leisenring W, Franke GN, Sorror M, Hoppe R, Maloney DG, Negrin RS, Shizuru JA, Sandmaier BM.

    Biol Blood Marrow Transplant. 2009 Oct;15(10):1314-22. Epub 2009 Aug 3.PMID: 19747640 [PubMed - in process]Related articles

    4.

    Tissue-specific homing and expansion of donor NK cells in allogeneic bone marrow transplantation.

    Olson JA, Zeiser R, Beilhack A, Goldman JJ, Negrin RS.

    J Immunol. 2009 Sep 1;183(5):3219-28. Epub 2009 Aug 5.PMID: 19657090 [PubMed - indexed for MEDLINE]Related articles

    5.

    Long-term follow-up of patients with diffuse large B-cell non-Hodgkin's lymphoma receiving purged autografts after induction failure.

    Benjamin JE, Chen GL, Cao TM, Cao PD, Wong RM, Sheehan K, Shizuru JA, Johnston LJ, Negrin RS, Lowksy R, Laport GG.

    Bone Marrow Transplant. 2009 Jul 13. [Epub ahead of print]PMID: 19597427 [PubMed - as supplied by publisher]Related articles

    6.

    Natural killer cells in allogeneic transplantation: effect on engraftment, graft- versus-tumor, and graft-versus-host responses.

    Gill S, Olson JA, Negrin RS.

    Biol Blood Marrow Transplant. 2009 Jul;15(7):765-76. Epub 2009 Apr 2. Review.PMID: 19539207 [PubMed - indexed for MEDLINE]Related articles

    7.

    TLI and ATG conditioning with low risk of graft-versus-host disease retains antitumor reactions after allogeneic hematopoietic cell transplantation from related and unrelated donors.

    Kohrt HE, Turnbull BB, Heydari K, Shizuru JA, Laport GG, Miklos DB, Johnston LJ, Arai S, Weng WK, Hoppe RT, Lavori PW, Blume KG, Negrin RS, Strober S, Lowsky R.

    Blood. 2009 Jul 30;114(5):1099-109. Epub 2009 May 7.PMID: 19423725 [PubMed - indexed for MEDLINE]Related articles

    8.

    Glycogen synthase kinase 3beta missplicing contributes to leukemia stem cell generation.

    Abrahamsson AE, Geron I, Gotlib J, Dao KH, Barroga CF, Newton IG, Giles FJ, Durocher J, Creusot RS, Karimi M, Jones C, Zehnder JL, Keating A, Negrin RS, Weissman IL, Jamieson CH.

    Proc Natl Acad Sci U S A. 2009 Mar 10;106(10):3925-9. Epub 2009 Feb 23.PMID: 19237556 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Regulation of different inflammatory diseases by impacting the mevalonate pathway.

    Zeiser R, Maas K, Youssef S, Dürr C, Steinman L, Negrin RS.

    Immunology. 2009 May;127(1):18-25. Review.PMID: 19191903 [PubMed - indexed for MEDLINE]Related articles

    10.

    Follicular lymphoma B cells induce the conversion of conventional CD4+ T cells to T-regulatory cells.

    Ai WZ, Hou JZ, Zeiser R, Czerwinski D, Negrin RS, Levy R.

    Int J Cancer. 2009 Jan 1;124(1):239-44.PMID: 18814264 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Impact of mammalian target of rapamycin inhibition on lymphoid homing and tolerogenic function of nanoparticle-labeled dendritic cells following allogeneic hematopoietic cell transplantation.

    Reichardt W, Dürr C, von Elverfeldt D, Jüttner E, Gerlach UV, Yamada M, Smith B, Negrin RS, Zeiser R.

    J Immunol. 2008 Oct 1;181(7):4770-9.PMID: 18802080 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Plasmacytoid dendritic cells take up opsonized antigen leading to CD4+ and CD8+ T cell activation in vivo.

    Björck P, Beilhack A, Herman EI, Negrin RS, Engleman EG.

    J Immunol. 2008 Sep 15;181(6):3811-7.PMID: 18768834 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    In vivo trafficking and survival of cytokine-induced killer cells resulting in minimal GVHD with retention of antitumor activity.

    Nishimura R, Baker J, Beilhack A, Zeiser R, Olson JA, Sega EI, Karimi M, Negrin RS.

    Blood. 2008 Sep 15;112(6):2563-74. Epub 2008 Jun 18.PMID: 18565854 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Long-term results of autologous hematopoietic cell transplantation for peripheral T cell lymphoma: the Stanford experience.

    Chen AI, McMillan A, Negrin RS, Horning SJ, Laport GG.

    Biol Blood Marrow Transplant. 2008 Jul;14(7):741-7.PMID: 18541192 [PubMed - indexed for MEDLINE]Related articles

    15.

    Long-term remission of Philadelphia chromosome-positive acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation from matched sibling donors: a 20-year experience with the fractionated total body irradiation-etoposide regimen.

    Laport GG, Alvarnas JC, Palmer JM, Snyder DS, Slovak ML, Cherry AM, Wong RM, Negrin RS, Blume KG, Forman SJ.

    Blood. 2008 Aug 1;112(3):903-9. Epub 2008 Jun 2.PMID: 18519812 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Interleukin-2 receptor downstream events in regulatory T cells: implications for the choice of immunosuppressive drug therapy.

    Zeiser R, Negrin RS.

    Cell Cycle. 2008 Feb 15;7(4):458-62. Epub 2007 Dec 18. Review.PMID: 18235249 [PubMed - indexed for MEDLINE]Related articles

    17.

    Acute graft-versus-host disease-challenge for a broader application of allogeneic hematopoietic cell transplantation.

    Zeiser R, Beilhack A, Negrin RS.

    Curr Stem Cell Res Ther. 2006 May;1(2):203-12. Review.PMID: 18220867 [PubMed - indexed for MEDLINE]Related articles

    18.

    Host-derived interleukin-18 differentially impacts regulatory and conventional T cell expansion during acute graft-versus-host disease.

    Zeiser R, Zambricki EA, Leveson-Gower D, Kambham N, Beilhack A, Negrin RS.

    Biol Blood Marrow Transplant. 2007 Dec;13(12):1427-38. Epub 2007 Oct 29.PMID: 18022572 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Prevention of acute graft-versus-host disease by blocking T-cell entry to secondary lymphoid organs.

    Beilhack A, Schulz S, Baker J, Beilhack GF, Nishimura R, Baker EM, Landan G, Herman EI, Butcher EC, Contag CH, Negrin RS.

    Blood. 2008 Mar 1;111(5):2919-28. Epub 2007 Nov 7.PMID: 17989315 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    A novel technique for the enrichment of primary ovarian cancer cells.

    Chan JK, Hamilton CA, Anderson EM, Cheung MK, Baker J, Husain A, Teng NN, Kong CS, Negrin RS.

    Am J Obstet Gynecol. 2007 Nov;197(5):507.e1-5.PMID: 17980191 [PubMed - indexed for MEDLINE]Related articles

    21.

    Differential impact of mammalian target of rapamycin inhibition on CD4+CD25+Foxp3+ regulatory T cells compared with conventional CD4+ T cells.

    Zeiser R, Leveson-Gower DB, Zambricki EA, Kambham N, Beilhack A, Loh J, Hou JZ, Negrin RS.

    Blood. 2008 Jan 1;111(1):453-62. Epub 2007 Oct 29.PMID: 17967941 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    Immune regulatory networks in the post-transplant setting.

    Negrin RS.

    Blood Cells Mol Dis. 2008 Jan-Feb;40(1):117-8. Epub 2007 Oct 24. No abstract available. PMID: 17920962 [PubMed - indexed for MEDLINE]Related articles

    23.

    The impact of regulatory T cells on T-cell immunity following hematopoietic cell transplantation.

    Nguyen VH, Shashidhar S, Chang DS, Ho L, Kambham N, Bachmann M, Brown JM, Negrin RS.

    Blood. 2008 Jan 15;111(2):945-53. Epub 2007 Oct 4.PMID: 17916743 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    Preemptive HMG-CoA reductase inhibition provides graft-versus-host disease protection by Th-2 polarization while sparing graft-versus-leukemia activity.

    Zeiser R, Youssef S, Baker J, Kambham N, Steinman L, Negrin RS.

    Blood. 2007 Dec 15;110(13):4588-98. Epub 2007 Sep 7.PMID: 17827390 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    CD101 surface expression discriminates potency among murine FoxP3+ regulatory T cells.

    Fernandez I, Zeiser R, Karsunky H, Kambham N, Beilhack A, Soderstrom K, Negrin RS, Engleman E.

    J Immunol. 2007 Sep 1;179(5):2808-14. Erratum in: J Immunol. 2007 Oct 15;179(8):5605. PMID: 17709494 [PubMed - indexed for MEDLINE]Related articlesFree article

    26.

    Methods for imaging cell fates in hematopoiesis.

    Duda J, Karimi M, Negrin RS, Contag CH.

    Methods Mol Med. 2007;134:17-34. Review.PMID: 17666740 [PubMed - indexed for MEDLINE]Related articles

    27.

    In vivo dynamics of regulatory T-cell trafficking and survival predict effective strategies to control graft-versus-host disease following allogeneic transplantation.

    Nguyen VH, Zeiser R, Dasilva DL, Chang DS, Beilhack A, Contag CH, Negrin RS.

    Blood. 2007 Mar 15;109(6):2649-56. Epub 2006 Nov 9.PMID: 17095616 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    Role of naturally arising regulatory T cells in hematopoietic cell transplantation.

    Nguyen VH, Zeiser R, Negrin RS.

    Biol Blood Marrow Transplant. 2006 Oct;12(10):995-1009. Review.PMID: 17084366 [PubMed - indexed for MEDLINE]Related articles

    29.

    Early CD30 signaling is critical for adoptively transferred CD4+CD25+ regulatory T cells in prevention of acute graft-versus-host disease.

    Zeiser R, Nguyen VH, Hou JZ, Beilhack A, Zambricki E, Buess M, Contag CH, Negrin RS.

    Blood. 2007 Mar 1;109(5):2225-33. Epub 2006 Oct 26.PMID: 17068147 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    The effects of imatinib mesylate treatment before allogeneic transplantation for chronic myeloid leukemia.

    Oehler VG, Gooley T, Snyder DS, Johnston L, Lin A, Cummings CC, Chu S, Bhatia R, Forman SJ, Negrin RS, Appelbaum FR, Radich JP.

    Blood. 2007 Feb 15;109(4):1782-9. Epub 2006 Oct 24.PMID: 17062727 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    High-dose carmustine, etoposide, and cyclophosphamide followed by allogeneic hematopoietic cell transplantation for non-Hodgkin lymphoma.

    Law LY, Horning SJ, Wong RM, Johnston LJ, Laport GG, Lowsky R, Shizuru JA, Blume KG, Negrin RS, Stockerl-Goldstein KE.

    Biol Blood Marrow Transplant. 2006 Jul;12(7):703-11.PMID: 16785059 [PubMed - indexed for MEDLINE]Related articles

    32.

    In vivo imaging using bioluminescence: a tool for probing graft-versus-host disease.

    Negrin RS, Contag CH.

    Nat Rev Immunol. 2006 Jun;6(6):484-90. Review.PMID: 16724101 [PubMed - indexed for MEDLINE]Related articles

    33.

    The apoptotic and proliferative fate of cytokine-induced killer cells after redirection to tumor cells with bispecific Ab.

    Kornacker M, Verneris M, Kornacker B, Ganten T, Scheffold C, Negrin R.

    Cytotherapy. 2006;8(1):13-23.PMID: 16627341 [PubMed - indexed for MEDLINE]Related articles

    34.

    Synergistic antitumor effects of immune cell-viral biotherapy.

    Thorne SH, Negrin RS, Contag CH.

    Science. 2006 Mar 24;311(5768):1780-4.PMID: 16556847 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    Enhanced killing of primary ovarian cancer by retargeting autologous cytokine-induced killer cells with bispecific antibodies: a preclinical study.

    Chan JK, Hamilton CA, Cheung MK, Karimi M, Baker J, Gall JM, Schulz S, Thorne SH, Teng NN, Contag CH, Lum LG, Negrin RS.

    Clin Cancer Res. 2006 Mar 15;12(6):1859-67.PMID: 16551871 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production.

    Zeiser R, Nguyen VH, Beilhack A, Buess M, Schulz S, Baker J, Contag CH, Negrin RS.

    Blood. 2006 Jul 1;108(1):390-9. Epub 2006 Mar 7.PMID: 16522809 [PubMed - indexed for MEDLINE]Related articlesFree article

    37.

    Silencing human NKG2D, DAP10, and DAP12 reduces cytotoxicity of activated CD8+ T cells and NK cells.

    Karimi M, Cao TM, Baker JA, Verneris MR, Soares L, Negrin RS.

    J Immunol. 2005 Dec 15;175(12):7819-28.PMID: 16339517 [PubMed - indexed for MEDLINE]Related articlesFree article

    38.

    Ex vivo expanded dendritic cells home to T-cell zones of lymphoid organs and survive in vivo after allogeneic bone marrow transplantation.

    Schimmelpfennig CH, Schulz S, Arber C, Baker J, Tarner I, McBride J, Contag CH, Negrin RS.

    Am J Pathol. 2005 Nov;167(5):1321-31.PMID: 16251416 [PubMed - indexed for MEDLINE]Related articlesFree article

    39.

    Protective conditioning for acute graft-versus-host disease.

    Lowsky R, Takahashi T, Liu YP, Dejbakhsh-Jones S, Grumet FC, Shizuru JA, Laport GG, Stockerl-Goldstein KE, Johnston LJ, Hoppe RT, Bloch DA, Blume KG, Negrin RS, Strober S.

    N Engl J Med. 2005 Sep 29;353(13):1321-31. Erratum in: N Engl J Med. 2006 Feb 23;354(8):884. PMID: 16192477 [PubMed - indexed for MEDLINE]Related articlesFree article

    40.

    Molecular imaging using labeled donor tissues reveals patterns of engraftment, rejection, and survival in transplantation.

    Cao YA, Bachmann MH, Beilhack A, Yang Y, Tanaka M, Swijnenburg RJ, Reeves R, Taylor-Edwards C, Schulz S, Doyle TC, Fathman CG, Robbins RC, Herzenberg LA, Negrin RS, Contag CH.

    Transplantation. 2005 Jul 15;80(1):134-9.PMID: 16003245 [PubMed - indexed for MEDLINE]Related articles

    41.

    Low levels of Her2/neu expressed by Ewing's family tumor cell lines can redirect cytokine-induced killer cells.

    Verneris MR, Arshi A, Edinger M, Kornacker M, Natkunam Y, Karami M, Cao YA, Marina N, Contag CH, Negrin RS.

    Clin Cancer Res. 2005 Jun 15;11(12):4561-70.PMID: 15958642 [PubMed - indexed for MEDLINE]Related articlesFree article

    42.

    In vivo analyses of early events in acute graft-versus-host disease reveal sequential infiltration of T-cell subsets.

    Beilhack A, Schulz S, Baker J, Beilhack GF, Wieland CB, Herman EI, Baker EM, Cao YA, Contag CH, Negrin RS.

    Blood. 2005 Aug 1;106(3):1113-22. Epub 2005 Apr 26.PMID: 15855275 [PubMed - indexed for MEDLINE]Related articlesFree article

    43.

    A phase I trial of autologous cytokine-induced killer cells for the treatment of relapsed Hodgkin disease and non-Hodgkin lymphoma.

    Leemhuis T, Wells S, Scheffold C, Edinger M, Negrin RS.

    Biol Blood Marrow Transplant. 2005 Mar;11(3):181-7.PMID: 15744236 [PubMed - indexed for MEDLINE]Related articles

    44.

    CD34, CD4, and CD8 cell doses do not influence engraftment, graft-versus-host disease, or survival following myeloablative human leukocyte antigen-identical peripheral blood allografting for hematologic malignancies.

    Cao TM, Wong RM, Sheehan K, Laport GG, Stockerl-Goldstein KE, Johnston LJ, Shizuru JA, Negrin RS, Lowsky R.

    Exp Hematol. 2005 Mar;33(3):279-85.PMID: 15730851 [PubMed - indexed for MEDLINE]Related articles

    45.

    Randomized trial of allogeneic related bone marrow transplantation versus peripheral blood stem cell transplantation for chronic myeloid leukemia.

    Oehler VG, Radich JP, Storer B, Blume KG, Chauncey T, Clift R, Snyder DS, Forman SJ, Flowers ME, Martin P, Guthrie KA, Negrin RS, Appelbaum FR, Bensinger W.

    Biol Blood Marrow Transplant. 2005 Feb;11(2):85-92.PMID: 15682068 [PubMed - indexed for MEDLINE]Related articles

    46.

    Hematopoietic stem and progenitor cells: clinical and preclinical regeneration of the hematolymphoid system.

    Shizuru JA, Negrin RS, Weissman IL.

    Annu Rev Med. 2005;56:509-38. Review.PMID: 15660525 [PubMed - indexed for MEDLINE]Related articles

    47.

    Rapamycin (sirolimus) for treatment of chronic graft-versus-host disease.

    Johnston LJ, Brown J, Shizuru JA, Stockerl-Goldstein KE, Stuart MJ, Blume KG, Negrin RS, Chao NJ.

    Biol Blood Marrow Transplant. 2005 Jan;11(1):47-55.PMID: 15625544 [PubMed - indexed for MEDLINE]Related articles

    48.

    Engraftment and survival following reduced-intensity allogeneic peripheral blood hematopoietic cell transplantation is affected by CD8+ T-cell dose.

    Cao TM, Shizuru JA, Wong RM, Sheehan K, Laport GG, Stockerl-Goldstein KE, Johnston LJ, Stuart MJ, Grumet FC, Negrin RS, Lowsky R.

    Blood. 2005 Mar 15;105(6):2300-6. Epub 2004 Nov 30.PMID: 15572597 [PubMed - indexed for MEDLINE]Related articlesFree article

    49.

    Only the CD62L+ subpopulation of CD4+CD25+ regulatory T cells protects from lethal acute GVHD.

    Ermann J, Hoffmann P, Edinger M, Dutt S, Blankenberg FG, Higgins JP, Negrin RS, Fathman CG, Strober S.

    Blood. 2005 Mar 1;105(5):2220-6. Epub 2004 Nov 16.PMID: 15546950 [PubMed - indexed for MEDLINE]Related articlesFree article

    50.

    Multi-modality imaging identifies key times for annexin V imaging as an early predictor of therapeutic outcome.

    Mandl SJ, Mari C, Edinger M, Negrin RS, Tait JF, Contag CH, Blankenberg FG.

    Mol Imaging. 2004 Jan;3(1):1-8.PMID: 15142407 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...